Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Global Market Report 2025

Description

Devices for chronic obstructive pulmonary disease (COPD) and asthma are medical tools designed to manage and treat breathing and respiratory issues. These devices assist patients in breathing more efficiently, controlling symptoms, and enhancing their overall quality of life.

Key types of these devices include metered dose inhalers, dry powder inhalers, soft mist inhalers, jet nebulizers, ultrasonic nebulizers, and others. Metered Dose Inhalers are portable devices that administer medication in a precise spray or mist, commonly used for conditions such as COPD and asthma by delivering the medication directly into the lungs. They are small and easy to carry, making them suitable for everyday use. These devices are utilized in various settings such as hospitals, clinics, home care, and research facilities, and cater to different age groups including pediatric, adult, and geriatric patients.

The chronic obstructive pulmonary disease (COPD) and asthma devices market research report is one of a series of new reports from The Business Research Company that provides chronic obstructive pulmonary disease (COPD) and asthma devices market statistics, including chronic obstructive pulmonary disease (COPD) and asthma devices industry global market size, regional shares, competitors with an chronic obstructive pulmonary disease (COPD) and asthma devices market share, detailed chronic obstructive pulmonary disease (COPD) and asthma devices market segments, market trends, and opportunities, and any further data you may need to thrive in the chronic obstructive pulmonary disease (COPD) and asthma devices industry. This chronic obstructive pulmonary disease (COPD) and asthma devices research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The chronic obstructive pulmonary disease (COPD) and asthma devices market size has grown strongly in recent years. It will grow from $44.95 billion in 2024 to $47.83 billion in 2025 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to growth in the elderly population, increasing incidence of allergies, increasing government initiatives, rise in clinical research and trials, and rise in urbanization.

The chronic obstructive pulmonary disease (COPD) and asthma devices market size is expected to see strong growth in the next few years. It will grow to $60.53 billion in 2029 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to rising occurrences of respiratory diseases, rising smoking of cigarettes, rising environmental pollution levels and breathing problems, growing prevalence of respiratory diseases, growing healthcare expenditure, and rising portability of drug delivery devices. Major trends in the forecast period include technological advancements, integration of smart technology, personalized medicine, adoption of biologics, and wearable respiratory monitors.

The increasing incidence of respiratory diseases is anticipated to drive the expansion of the chronic obstructive pulmonary disease (COPD) and asthma devices market. Respiratory diseases include various conditions that affect the lungs and respiratory system, such as asthma, COPD, pneumonia, and lung cancer, which impact breathing and overall respiratory function. The rising prevalence of these diseases is linked to factors such as escalating air pollution, climate changes that influence allergens and pathogens, and lifestyle choices such as smoking that impair respiratory health. Devices designed for COPD and asthma are essential for effective management and treatment of these conditions, helping patients achieve better respiratory health and improved overall well-being. For example, as reported by the World Health Organization (WHO) in March 2023, COPD was the third leading cause of death worldwide, accounting for about 3.23 million deaths, with nearly 90% of these fatalities occurring in low- and middle-income countries (LMICs) among individuals under 70 years old. This rising prevalence of respiratory diseases is fueling growth in the COPD and asthma devices market.

Leading companies in the COPD and asthma devices market are concentrating on creating innovative technologies, such as inhalation devices with integrated digital health features for remote monitoring and personalized treatment. Inhalation devices are used to deliver medication directly to the lungs through inhalation. For instance, in May 2022, Alkem Laboratories, an Indian pharmaceutical company, launched the Innohaler, a dry powder inhaler (DPI) designed to improve the lives of people with asthma and COPD. The Innohaler features advanced breath-actuated technology for accurate medication delivery with each inhalation, enhancing dosage precision and minimizing waste. Its ergonomic design makes it easy to use, with a user-friendly interface suitable for patients of all ages. Additionally, its compact and portable design increases convenience for use on the go, supporting better adherence to treatment regimens.

In March 2022, Philip Morris International Inc., a US-based tobacco company, acquired Vectura Group plc. for an undisclosed amount. This acquisition is aimed at utilizing Vectura's expertise in inhalation technology to advance the development of reduced-risk products (RRPs) and other non-combustible alternatives. Vectura Group plc, a UK-based pharmaceutical company, specializes in inhaled medicines and inhaler devices for treating respiratory diseases such as asthma and COPD.

Major companies operating in the chronic obstructive pulmonary disease (COPD) and asthma devices market are AstraZeneca Plc, Novartis AG, GlaxoSmithKline Plc, 3M Health Care, Boehringer Ingelheim, Royal Philips NV, Teva Pharmaceuticals Industries Ltd., Baxter International Inc., Omron Corporation, Smiths Medical Inc., Recipharm AB, Cipla Ltd., Teleflex Incorporated, Chiesi Farmaceutici SpA, Lincre Holdings Inc., Sunovion Pharmaceuticals Inc., Verona Pharma plc, Drive DeVilbiss Healthcare, Pari Respiratory Equipment Inc., Allied Healthcare Products Inc., Clement Clarke International Ltd., Cohero Health Inc., Pneuma Respiratory Inc., Mundipharma International Ltd.

North America was the largest region in the chronic obstructive pulmonary disease (COPD) and asthma devices market in 2024. The regions covered in the chronic obstructive pulmonary disease (COPD) and asthma devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the chronic obstructive pulmonary disease (COPD) and asthma devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The chronic obstructive pulmonary disease (COPD) and asthma devices market consists of sales of spacer devices, peak flow meters, oxygen therapy equipment, pulse oximeters, and airway clearance devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on chronic obstructive pulmonary disease (copd) and asthma devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for chronic obstructive pulmonary disease (copd) and asthma devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The chronic obstructive pulmonary disease (copd) and asthma devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Metered Dose Inhalers; Drug Powder Inhalers; Soft Mist Inhalers; Jet Nebulizers; Ultrasonic Nebulizers; Other Types
2) By Indication: Asthma; Chronic Obstructive Pulmonary Disease
3) By Application: Hospitals; Clinics; Home Care Settings; Research Institutions; Other Applications
4) By End User: Pediatric; Adult; Geriatric
Subsegments:
1) By Metered Dose Inhalers: Conventional MDI; Breath-Actuated MDI
2) By Drug Powder Inhalers: Dry Powder Inhalers (DPI); Multi-Dose DPI
3) By Soft Mist Inhalers: Respimat Soft Mist Inhalers; Other Soft Mist Devices
4) By Jet Nebulizers: Pneumatic Nebulizers; Venturi-Type Nebulizers
5) By Ultrasonic Nebulizers: Tabletop Ultrasonic Nebulizers; Portable Ultrasonic Nebulizers
6) By Other Types: Nebulizer Accessories; Spacer Devices
Companies Mentioned: AstraZeneca Plc; Novartis AG; GlaxoSmithKline Plc; 3M Health Care; Boehringer Ingelheim
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r29784

1. Executive Summary

2. Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Characteristics

3. Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Trends And Strategies

4. Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Growth Analysis And Strategic Analysis Framework

5.1. Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Growth Rate Analysis
5.4. Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Total Addressable Market (TAM)

6. Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Segmentation

6.1. Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Metered Dose Inhalers
Drug Powder Inhalers
Soft Mist Inhalers
Jet Nebulizers
Ultrasonic Nebulizers
Other Types
6.2. Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Asthma
Chronic Obstructive Pulmonary Disease
6.3. Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
Home Care Settings
Research Institutions
Other Applications
6.4. Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pediatric
Adult
Geriatric
6.5. Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Sub-Segmentation Of Metered Dose Inhalers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Conventional MDI
Breath-Actuated MDI
6.6. Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Sub-Segmentation Of Drug Powder Inhalers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Dry Powder Inhalers (DPI)
Multi-Dose DPI
6.7. Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Sub-Segmentation Of Soft Mist Inhalers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Respimat Soft Mist Inhalers
Other Soft Mist Devices
6.8. Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Sub-Segmentation Of Jet Nebulizers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pneumatic Nebulizers
Venturi-Type Nebulizers
6.9. Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Sub-Segmentation Of Ultrasonic Nebulizers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Tabletop Ultrasonic Nebulizers
Portable Ultrasonic Nebulizers
6.10. Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Nebulizer Accessories
Spacer Devices

7. Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Regional And Country Analysis

7.1. Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

8.1. Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

9.1. China Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Overview
9.2. China Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

10.1. India Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

11.1. Japan Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Overview
11.2. Japan Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

12.1. Australia Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

13.1. Indonesia Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

14.1. South Korea Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Overview
14.2. South Korea Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

15.1. Western Europe Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Overview
15.2. Western Europe Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

16.1. UK Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

17.1. Germany Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

18.1. France Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

19.1. Italy Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

20.1. Spain Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

21.1. Eastern Europe Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Overview
21.2. Eastern Europe Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

22.1. Russia Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

23.1. North America Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Overview
23.2. North America Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

24.1. USA Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Overview
24.2. USA Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

25.1. Canada Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Overview
25.2. Canada Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

26.1. South America Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Overview
26.2. South America Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

27.1. Brazil Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

28.1. Middle East Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Overview
28.2. Middle East Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

29.1. Africa Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Overview
29.2. Africa Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Competitive Landscape And Company Profiles

30.1. Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Competitive Landscape
30.2. Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Company Profiles
- 30.2.1. AstraZeneca Plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. GlaxoSmithKline Plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. 3M Health Care Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Boehringer Ingelheim Overview, Products and Services, Strategy and Financial Analysis

31. Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Other Major And Innovative Companies

31.1. Royal Philips NV
31.2. Teva Pharmaceuticals Industries Ltd.
31.3. Baxter International Inc.
31.4. Omron Corporation
31.5. Smiths Medical Inc.
31.6. Recipharm AB
31.7. Cipla Ltd.
31.8. Teleflex Incorporated
31.9. Chiesi Farmaceutici SpA
31.10. Lincre Holdings Inc.
31.11. Sunovion Pharmaceuticals Inc.
31.12. Verona Pharma plc
31.13. Drive DeVilbiss Healthcare
31.14. Pari Respiratory Equipment Inc.
31.15. Allied Healthcare Products Inc.

32. Global Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

34. Recent Developments In The Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market

35. Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market High Potential Countries, Segments and Strategies

35.1 Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market In 2029 - Countries Offering Most New Opportunities
35.2 Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market In 2029 - Segments Offering Most New Opportunities
35.3 Chronic Obstructive Pulmonary Disease (COPD) And Asthma Devices Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer